Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Serra Muftu"'
Autor:
Ana Claudia Amaral, Beatriz G. Perez-Nievas, Michael Siao Tick Chong, Alicia Gonzalez-Martinez, Herminia Argente-Escrig, Sara Rubio-Guerra, Caitlin Commins, Serra Muftu, Bahareh Eftekharzadeh, Eloise Hudry, Zhanyun Fan, Prianca Ramanan, Shuko Takeda, Matthew P. Frosch, Susanne Wegmann, Teresa Gomez-Isla
Publikováno v:
iScience, Vol 24, Iss 2, Pp 102058- (2021)
Summary: It has been suggested that aberrant activation of glycogen synthase kinase-3-beta (GSK-3β) can trigger abnormal tau hyperphosphorylation and aggregation, which ultimately leads to neuronal/synaptic damage and impaired cognition in Alzheimer
Externí odkaz:
https://doaj.org/article/0834daf1f0d14cb1bd40b2f5ea69e654
Autor:
Erin C. Work, Serra Muftu, Kathryn Dee L. MacMillan, Jessica R. Gray, Nicole Bell, Mishka Terplan, Hendree E. Jones, Julia Reddy, Timothy E. Wilens, Shelly F. Greenfield, Judith Bernstein, Davida M. Schiff
Objectives Some states, including Massachusetts, require automatic filing of child abuse and neglect for substance-exposed newborns, including infants exposed in-utero to clinician-prescribed medications to treat opioid use disorder (MOUD). The aim o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a50f0932a89be0ef1f4582c4520750c
https://escholarship.org/uc/item/93j073zv
https://escholarship.org/uc/item/93j073zv
Autor:
Davida M. Schiff, Erin C. Work, Serra Muftu, Shayla Partridge, Kathryn Dee L. MacMillan, Jessica R. Gray, Bettina B. Hoeppner, John F. Kelly, Shelly F. Greenfield, Hendrée E. Jones, Timothy E. Wilens, Mishka Terplan, Judith Bernstein
Publikováno v:
Journal of substance abuse treatment. 139
Medications to treat opioid use disorder (MOUD) during pregnancy and in the postpartum period remain underutilized. A need exists to enhance our understanding of modifiable factors, facilitators, and barriers to MOUD utilization and adherence in the
Autor:
Teresa Gomez-Isla, Shuko Takeda, Prianca Ramanan, Caitlin Commins, Alicia Gonzalez-Martinez, Beatriz G. Pérez-Nievas, Ana C. Amaral, Sara Rubio-Guerra, Susanne Wegmann, Bahareh Eftekharzadeh, Herminia Argente-Escrig, Zhanyun Fan, Matthew P. Frosch, Michael Siao Tick Chong, Serra Muftu, Eloise Hudry
Publikováno v:
iScience, Vol 24, Iss 2, Pp 102058-(2021)
iScience
iScience
Summary It has been suggested that aberrant activation of glycogen synthase kinase-3-beta (GSK-3β) can trigger abnormal tau hyperphosphorylation and aggregation, which ultimately leads to neuronal/synaptic damage and impaired cognition in Alzheimer